Tag: Huang Chao
Fangda, MoFo steer USD900m Boomray-Novartis licence agreement
Boomray Pharmaceuticals enters into an exclusive global licence agreement valued at up to USD900 million with Novartis for a preclinical radioligand therapy
Firms advise on WuXi AppTec’s China clinical research sale
WuXi AppTec has sold its China clinical research services business to Hillhouse Investment
Grandall acts on Avatr’s RMB11.5bn stake in Huawei auto unit
Grandall Law Firm advises on Avatr Technology's RMB11.5 billion stake in Huawei's Newcool subsidiary, advancing the automotive industry















